SXTP

60 Degrees Pharmaceuticals, Inc. Common Stock

0.59

USD

-0.32

-35.08%

Nov 06, 15:59 UTC -5

Closed

After-Market

0.60

+0.01

+1.03%

60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) Earnings

SXTP Earnings Reports

Positive Surprise Ratio

SXTP beat 2 of 12 last estimates.

17%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q2 26 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

60 Degrees Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Aug 14, 2026, SXTP reported earnings of -0.90 USD per share (EPS) for Q2 26, missing the estimate of -0.69 USD, resulting in a -29.76% surprise. Revenue reached 208.00 thousand, compared to an expected 188.70 thousand, with a 10.23% difference. The market reacted with a +1.27% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

ZOETIS INC.

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.52

Actual

$1.75

Surprise

+14.64%

Amylyx Pharmaceuticals, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.38

Actual

-$0.38

Surprise

+1.04%

Guardian Pharmacy Services, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.30

Actual

$0.33

Surprise

+7.84%

Xeris Biopharma Holdings, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.02

Actual

$0.06

Surprise

+144.90%

Cronos Group Inc. Common Share

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.03

Actual

$0.04

Surprise

+17.65%

Collegium Pharmaceutical, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.89

Actual

$1.96

Surprise

+3.17%

Ironwood Pharmaceuticals, Inc. - Class A

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.32

Actual

$0.36

Surprise

+9.16%

ARS Pharmaceuticals, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.32

Actual

-$0.36

Surprise

-11.15%

Profound Medical Corp. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.18

Actual

-$0.21

Surprise

-11.41%

Akebia Therapeutics, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.03

Actual

-$0.04

Surprise

-6.95%

FAQ

What were 60 Degrees Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, 60 Degrees Pharmaceuticals, Inc. Common Stock reported EPS of -$0.90, missing estimates by -29.76%, and revenue of $208.00K, 10.23% above expectations.

How did the market react to 60 Degrees Pharmaceuticals, Inc. Common Stock's Q2 2026 earnings?

The stock price moved up 1.27%, changed from $1.18 before the earnings release to $1.20 the day after.

When is 60 Degrees Pharmaceuticals, Inc. Common Stock expected to report next?

The next earning report is scheduled for --.

What are the forecasts for 60 Degrees Pharmaceuticals, Inc. Common Stock's next earnings report?

Based on -- analysts, 60 Degrees Pharmaceuticals, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.